LivaloVA
N/A
Report date: 2024/11/04 16:56:55
Base Information
Drug NameLivaloVA
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassN/A
Develop Information
Active CompaniesJw Pharmaceutical Corp
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A